Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

07 August 2002

Levels of F1+2 prothrombin fragments and thrombin – antithrombin III (TAT) complexes in patients with dermatitis herpetiformis

Anna Wankiewicz, Iza Iwan-Ziętek, Zenon Gwieździński, Maria Kotschy

Med Sci Monit 2002; 8(8): BR324-327 :: ID: 13592

Abstract

Background: Dermatitis herpetiformis (DH) is a rare bullous disease of autoimmune etiology. It is an intestinocutaneous syndrome, in which vesicopapular cutaneous lesions are accompanied by gluten-dependent enteropathy. The diagnosis of DH is based on immunopathological investigation of unaffected skin fragment (granular IgA deposits present at the tops of dermal papillae and IgA – EmA present in the serum).
Material/Methods: The studied group consisted of 33 patients with dermatitis herpetiformis – 23 males and 10 females aged 22–78 (mean age 44.7). In all the patients, the following parameters of blood
coagulation systems were determined in the plasma Levels of prothrombin fragments 1+2 (F1+2), levels of thrombin – antithrombin III (TAT) complexes, antithrombin III activity (AT III).
Results: In patients with dermatitis herpetiformis, the main level of F1+2 fragments amounted to 9.08 nmol/l, as compared with 1.14 nmol/l in the control group (the difference statistically significant,
p

Keywords: Antithrombin III, Blood Coagulation Tests, Dermatitis Herpetiformis - blood, Dermatitis Herpetiformis - immunology, Peptide Fragments - blood, Peptide Hydrolases - blood, Prothrombin

Add Comment 0 Comments

Editorial

01 March 2025 : Editorial  

Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials

Dinah V. Parums

DOI: 10.12659/MSM.948672

Med Sci Monit 2025; 31:e948672

0:00

In Press

Clinical Research  

Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.945964  

Clinical Research  

Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum Hypertrophy

Med Sci Monit In Press; DOI: 10.12659/MSM.947508  

Clinical Research  

Balancing Image Quality and Iodine Intake: Insights from CT Spectral Imaging of the Portal Vein

Med Sci Monit In Press; DOI: 10.12659/MSM.947391  

Review article  

Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.947124  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,160,485

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,385

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   27,806

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   22,071

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750